NTCOC
RPRX

Northern Trust Company of Connecticut’s Repros Therapeutics Inc. RPRX Stock Holding History

Northern Trust Company of Connecticut’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$76K Hold
4,136
– – ﹤0.01% 1904
2013
Q3 		$111K Hold
4,136
– – ﹤0.01% 1843
2013
Q2 		$76K Buy
+4,136
New +$73K ﹤0.01% 1851

Other funds holding RPRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Company of Connecticut's RPRX Position: Q4 2013 in Review

Northern Trust Company of Connecticut held its Repros Therapeutics Inc. (RPRX) position steady in Q4 2013 at 4,136 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #1904.

Northern Trust Company of Connecticut first reported a position in RPRX in Q2 2013 and has held it in 3 quarters since. The position peaked at $111K in Q3 2013. 79 funds tracked by Wall St. Rank hold RPRX as of Q4 2013.

  • Northern Trust Company of Connecticut held 4,136 shares of Repros Therapeutics Inc. worth $76K as of Q4 2013.
  • Northern Trust Company of Connecticut left its Repros Therapeutics Inc. share count unchanged in Q4 2013.
  • Repros Therapeutics Inc. made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1904 holding.
  • Northern Trust Company of Connecticut first reported a position in Repros Therapeutics Inc. in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Repros Therapeutics Inc. position peaked at $111K in Q3 2013.
  • 79 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.